STOCK TITAN

Amesite signs NurseMagic deal with ~2,000-patient provider

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

Amesite Inc. announced a new NurseMagic® enterprise agreement with a healthcare organization serving approximately 2,000 patients. Amesite said the agreement expands its customer portfolio into healthcare services for rural Medicare and Medicaid populations. NurseMagic is described as automating clinical documentation, EMR assessments, care plans and forms within customers’ existing systems; NurseMagic Record also supports offline capture with later synchronization.

Amesite’s Head of Engineering said the company ships more than 13 times as much code each quarter as in the first quarter of 2025, with a further 37% increase in the third quarter of 2026 over the second quarter. Its Director of Corporate Operations said median customer census at signing increased 4x from 2025 to 2026.

Item 8.01 Other Events Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Patients served by new enterprise customer Approximately 2,000 patients Healthcare organization under the NurseMagic enterprise agreement
Quarterly code output More than 13 times as much code Compared with the first quarter of 2025, according to Amesite’s Head of Engineering
Quarterly code output change 37% increase Third quarter of 2026 over the second quarter of 2026, according to Amesite’s Head of Engineering
Median customer census at signing Increased 4x 2025 to 2026, according to Amesite’s Director of Corporate Operations
Combined annual healthcare spending Approximately $456.9 billion Estimated 2026 Medicaid and Medicare spending for rural populations described in the release
U.S. market size Approximately $1.5 trillion Estimated combined market size of segments represented by Amesite’s customer portfolio
EMR technical
"electronic medical record (EMR) assessments"
An electronic medical record (EMR) is a digital version of a patient’s paper chart used by a single clinic or hospital to store medical history, test results, prescriptions and treatment notes. For investors, EMR systems matter because they drive recurring software and service revenue, affect healthcare providers’ costs and efficiency, and carry regulatory, privacy and interoperability risks that can influence adoption, contract value and long‑term market growth.
HIPAA-aligned infrastructure regulatory
"existing secure, HIPAA-aligned infrastructure"
ambient recording technical
"secure ambient and mobile recording"
offline capture technical
"including offline capture with automatic synchronization"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many patients does Amesite’s new NurseMagic customer serve?

The healthcare organization covered by the new enterprise agreement serves approximately 2,000 patients.

Which healthcare populations does the new Amesite agreement serve?

Amesite said the agreement expands its customer portfolio into healthcare services for rural Medicare and Medicaid populations.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false 0001807166 0001807166 2026-11-16 2026-11-16 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): November 16, 2026

 

Amesite Inc.

(Exact name of registrant as specified in its charter)

 

Delaware   001-39553   82-3431718

(State or other jurisdiction

of incorporation)

  (Commission File Number)  

(IRS Employer

Identification No.)

 

607 Shelby Street

Suite 700 PMB 214

Detroit, MI

  48226
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (734) 876-8141

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.0001 per share   AMST   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

Item 8.01 Other Events.

 

On November 16, 2026, Amesite Inc. issued a press release announcing a new NurseMagic® enterprise agreement with a healthcare organization serving approximately 2,000 patients. A copy of the press release is attached hereto as Exhibit 99.1 to this Current Report and is incorporated by reference herein.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit No.   Description
99.1   Press release dated November 16, 2026
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

1

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  AMESITE INC.
     
Date: November 17, 2026 By: /s/ Ann Marie Sastry, Ph.D.
  Name: Ann Marie Sastry, Ph.D.
  Title: Chief Executive Officer

 

2

 

 

Exhibit 99.1

 

Amesite Signs New 2,000-Patient NurseMagic® Enterprise Customer, Extending Growth Among Large Healthcare Organizations

 

Amesite announces its latest major enterprise win, increasing its revenue and deploying AI automations for another large healthcare organization in just days on its secure, AI-native infrastructure.

 

DETROIT, November 16, 2026 (GLOBE NEWSWIRE) -- Amesite Inc. (Nasdaq: AMST), an adaptive AI technology company and developer of the AI-native NurseMagic® documentation platform and LynkMagic™ enterprise solutions, today announced a new NurseMagic® enterprise agreement with a healthcare organization serving approximately 2,000 patients.

 

The contract ramps Amesite’s revenue, user base and patient census, and demonstrates another large company win for the Company’s portfolio. This announcement follows other substantial wins including a sales win under the minimum pricing model, a 2,700-census enterprise customer win in May 2026, a trading partner agreement enabling secure connectivity with an established homecare technology platform in March 2026, and the launch of its AI-native NurseMagic® EMR in December 2025. These milestones demonstrate continued execution of the Company's strategy to expand NurseMagic® adoption among larger healthcare organizations.

 

Amesite combines AI-native engineering with enterprise-scale execution, deploying sophisticated, production-ready AI systems in days rather than months. This capability enables Amesite to deliver enterprise-scale solutions with exceptional speed and efficiency, supporting attractive, high-margin subscription economics for mid-sized organizations while meeting the complex demands of large healthcare enterprises.

 

Dr. Ann Marie Sastry, Founder and CEO of Amesite, said, “We demonstrate production-ready AI systems during enterprise sales discussions and deploy customer-specific capabilities in days, not months. Our AI-native infrastructure enables us to meet complex healthcare requirements without lengthy development cycles or replacement of customers' existing systems. We are now converting these engineering advantages into larger enterprise agreements and recurring revenue opportunities.”

 

NurseMagic® automates work beyond transcription, transforming patient encounters into structured documentation and completing customer-specific electronic medical record (EMR) assessments, care plans, and forms. Its production capabilities include identifying missing information, generating targeted follow-up questions, and populating existing EMR workflows. NurseMagic® Record adds secure ambient and mobile recording, including offline capture with automatic synchronization when connectivity returns.

 

Together, these capabilities enable sophisticated enterprise automation within existing healthcare infrastructure. No rip and replace.

 

Kalie Wortinger, Head of Engineering at Amesite, said, “Our AI-native engineering infrastructure enables us to deliver increasingly sophisticated enterprise solutions at exceptional speed. We now ship more than 13 times as much code each quarter as we did in the first quarter of 2025, with another 37% increase in the third quarter of 2026 over the second quarter, all without adding engineers. By building customer-specific capabilities on our existing secure, HIPAA-aligned infrastructure, we can bring new products into production in days and deliver new features in hours, allowing us to serve increasingly complex healthcare enterprises efficiently and at scale.”

 

Sai K. Nittala, Head of AI at Amesite, said, “Large healthcare organizations have established technology stacks, but many of the documentation tasks within those systems remain entrenched, tedious, and expensive to perform. Our agility allows us to fill those gaps quickly with AI capabilities tailored to different care settings and operational requirements. We deliver complex customer-specific solutions and sit on top of existing systems. This enables us to build value and ramp sales with large enterprises, without rebuilding our core platform.”

 

 

Madison Bush, Director of Corporate Operations at Amesite, said, "Our marketing results are measurable: median customer census at signing has increased 4x from 2025 to 2026, demonstrating our progress in attracting larger organizations and converting market intelligence into enterprise sales.”

 

Amesite has methodically expanded its customer base with increasingly large healthcare market segments, progressing from hospice and home care to skilled nursing, senior living, and enterprise workflows serving Medicare and Medicaid populations. Each expansion has built on the Company's existing AI infrastructure, positioning Amesite to serve increasingly complex organizations across the U.S. non-acute and post-acute healthcare markets.

 

This most recent contract win expands Amesite’s customer portfolio into healthcare services for rural Medicare and Medicaid populations. Across the U.S., this segment comprises 64.5 million rural Americans, including 17.8 million Medicaid enrollees and 11.8 million Medicare beneficiaries. Based on projected 2026 spending per enrollee, these populations represent an estimated $232.9 billion in annual Medicaid spending and $224.0 billion in Medicare spending, respectively, totaling approximately $456.9 billion in combined annual healthcare spending. Overall, segments represented by customers in Amesite's portfolio have a combined estimated U.S. market size of approximately $1.5 trillion.

 

About Amesite Inc.

 

Amesite (NASDAQ: AMST) is an AI-driven company with an immediate aim to transform the $1.5 trillion non-acute care segments. Its flagship product, NurseMagic®, streamlines documentation for nurses and caregivers, reducing the time required from 20 minutes to just 20 seconds. NurseMagic® is used by over 100 professions to improve care, enhance operational efficiency and improve financial performance.

 

Built on proprietary AI trained on industry-specific data, NurseMagic® meets HIPAA regulations while improving accuracy and efficiency. The platform serves B2B and B2C users across 50 states and 21 countries, offering seamless integration into healthcare workflows and translations to over 50 languages.

 

Forward-Looking Statement

 

This communication contains forward-looking statements (including within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended) concerning the Company and its business.

 

Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as “may,” “will,” “should,” “would,” “expect,” “plan,” “believe,” “intend,” “look forward,” and other similar expressions among others. Statements that are not historical facts are forward-looking statements.

 

Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those contained in any forward-looking statement. Risks facing the Company and its business are set forth in the Company's filings with the SEC.

 

Except as required by applicable law, the Company undertakes no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.

 

Investor Relations

 

ir@amesite.com

 

 

 

Filing Exhibits & Attachments

4 documents

Keep reading